J&J Ionsys fentanyl pump for post-surgical pain to launch in 2007
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson subsidiary Alza will launch in 2007 its Ionsys needle-free, patient-activated iontophoresis transdermal fentanyl drug delivery system for post-operative pain, the firm says. FDA approved the system May 22 for short-term management of post-operative pain in adults requiring opioid analgesia during hospitalization. Ionsys' E-Trans delivery technology uses low-intensity electrical current to move a 40 mcg dose of fentanyl from a reservoir into the skin over a 10-minute period. Alza also markets the controlled-release fentanyl patch Duragesic. The road to approval for Ionsys has been relatively long. A September 2003 NDA filing was deemed "approvable" in July 2004. The company resubmitted the application in November 2005...
You may also be interested in...
Transport Pharma Targets Cold Sores With Drug-Device Combination Product
A combination product that delivers drugs through the skin via low-voltage electric current could represent an affordable approach to treating cold sores, according to Transport Pharmaceuticals
Clarification
"The Gray Sheet" incorrectly characterized Johnson & Johnson's Ionsys transdermal, on-demand analgesic drug dosing system as a pump. The device uses iontophoresis to deliver fentanyl (1"The Gray Sheet" May 29, 2006, In Brief)...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.